Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait

References

• Evans AE, D'Angio GJ, Randolph J. A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer 1971; 27:374-8; PMID:5100400; http://dx.doi.org/10.1002/1097-0142(197102)27:2%3c374::AID-CNCR2820270221%3e3.0.CO;2-G
   PubMed Web of Science ®Google Scholar
• Evans AE, Albo V, D'Angio GJ, Finklestein JZ, Leiken S, Santulli T, Weiner J, Hammond GD. Factors influencing survival of children with nonmetastatic neuroblastoma. Cancer 1976; 38:661-6; PMID:788890; http://dx.doi.org/10.1002/1097-0142(197608)38:2%3c661::AID-CNCR2820380206%3e3.0.CO;2-M
   PubMed Web of Science ®Google Scholar
• Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11:1466-77; PMID:8336186; http://dx.doi.org/0732-183X/93/1108-0006$3.00/0
   PubMed Web of Science ®Google Scholar
• London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, et al. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol 2005; 23:6459-65; PMID:16116153; http://dx.doi.org/10.1200/JCO.2005.05.571
   PubMed Web of Science ®Google Scholar
• Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009; 27:298-303; PMID:19047290; http://dx.doi.org/10.1200/JCO.2008.16.6876
   PubMed Web of Science ®Google Scholar
• Brodeur GM, Bagatell R. Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol 2014; 11:704-13; PMID:25331179; http://dx.doi.org/10.1038/nrclinonc.2014.168
   PubMed Web of Science ®Google Scholar
• Decock A, Ongenaert M, Van Criekinge W, Speleman F, Vandesompele J. DNA methylation profiling of primary neuroblastoma tumors using methyl-CpG-binding domain sequencing. Sci Data 2016; 3:160004; PMID:26836295; http://dx.doi.org/10.1038/sdata.2016.4
   PubMedGoogle Scholar
• Decock A, Ongenaert M, Cannoodt R, Verniers K, De Wilde B, Laureys G, Van Roy N, Berbegall AP, Bienertova-Vasku J, Bown N, et al. Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma. Oncotarget 2016; 7:1960-72; PMID:26646589; http://dx.doi.org/10.18632/oncotarget.6477
   PubMed Web of Science ®Google Scholar
• Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005; 33:W741-8; PMID:15980575; http://dx.doi.org/10.1093/nar/gki475
   PubMed Web of Science ®Google Scholar
• Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 2013; 41:W77-83; PMID:23703215; http://dx.doi.org/10.1093/nar/gkt439
   PubMed Web of Science ®Google Scholar
• Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995; 1:249-55; PMID:7585042; http://dx.doi.org/10.1038/nm0395-249
   PubMed Web of Science ®Google Scholar
• Onitake Y, Hiyama E, Kamei N, Yamaoka H, Sueda T, Hiyama K. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres. J Pediatr Surg 2009; 44:2258-66; PMID:20006006; http://dx.doi.org/10.1016/j.jpedsurg.2009.07.046
   PubMed Web of Science ®Google Scholar
• Valentijn LJ, Koster J, Zwijnenburg DA, Hasselt NE, van Sluis P, Volckmann R, van Noesel MM, George RE, Tytgat GAM, Molenaar JJ, et al. TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors. Nat Genet 2015; 47:1411-4; PMID:26523776; http://dx.doi.org/10.1038/ng.3438
   PubMed Web of Science ®Google Scholar
• Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, Krämer A, Roncaioli JL, Sand F, Heuckmann JM, et al. Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature 2015; 526:700-4; PMID:26466568; http://dx.doi.org/10.1038/nature14980
   PubMed Web of Science ®Google Scholar
• Blasco MA. The epigenetic regulation of mammalian telomeres. Nat Rev Genet 2007; 8:299-309; PMID:17363977; http://dx.doi.org/10.1038/nrg2047
   PubMed Web of Science ®Google Scholar
• Vera E, Canela A, Fraga MF, Esteller M, Blasco MA. Epigenetic regulation of telomeres in human cancer. Oncogene 2008; 27:6817-33; PMID:18762811; http://dx.doi.org/10.1038/onc.2008.289
   PubMed Web of Science ®Google Scholar
• Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, König R, Haas S, Eils R, et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 2006; 24:5070-8; PMID:17075126; http://dx.doi.org/10.1200/JCO.2006.06.1879
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102:15545-50; PMID:16199517; http://dx.doi.org/10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Goeman JJ, Van de Geer SA, De Kort F, van Houwellingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004; 20:93-9; PMID:14693814; http://dx.doi.org/10.1093/bioinformatics/btg382
   PubMed Web of Science ®Google Scholar
• Gómez S, Castellano G, Mayol G, Suñol M, Queiros A, Bibikova M, Nazor KL, Loring JF, Lemos I, Rodríguez E, et al. DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights. Epigenomics 2015; 7:1137-53; PMID:26067621; http://dx.doi.org/10.2217/epi.15.49
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, Paietta E, Fernandez H, Tallman MS, Greally JM, Carraway H, et al. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 2009; 114:3448-58; PMID:19652201; http://dx.doi.org/10.1182/blood-2009-01-200519
   PubMed Web of Science ®Google Scholar
• Heuck CJ, Mehta J, Bhagat T, Gundabolu K, Yu Y, Khan S, Chrysofakis G, Schinke C, Tariman J, Vickrey E, et al. Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis. J Immunol 2013; 190:2966-75; PMID:23408834; http://dx.doi.org/10.4049/jimmunol.1202493
   PubMed Web of Science ®Google Scholar
• Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am J Pathol 2003; 162:1019-26; PMID:12598334; http://dx.doi.org/10.1016/S0002-9440(10)63896-5
   PubMed Web of Science ®Google Scholar
• Buckley PG, Das S, Bryan K, Watters KM, Alcock L, Koster J, Versteeg R, Stallings RL. Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions. Int J Cancer 2011; 128:2296-305; PMID:20669225; http://dx.doi.org/10.1002/ijc.25584
   PubMed Web of Science ®Google Scholar
• Hertwig F, Peifer M, Fischer M. Telomere maintenance is pivotal for high-risk neuroblastoma. Cell Cycle 2016; 15:311-2; PMID:26653081; http://dx.doi.org/10.1080/15384101.2015.1125243
   PubMed Web of Science ®Google Scholar
• Blattler A, Farnham PJ. Cross-talk between site-specific transcription factors and DNA methylation states. J Biol Chem 2013; 288:34287-94; PMID:24151070; http://dx.doi.org/10.1074/jbc.R113.512517
   PubMed Web of Science ®Google Scholar
• Campanero MR, Armstrong MI, Flemington EK. CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci USA 2000; 97:6481-6; PMID:10823896; http://dx.doi.org/10.1073/pnas.100340697
   PubMed Web of Science ®Google Scholar
• Mann IK, Chatterjee R, Zhao J, He X, Weirauch MT, Hughes TR, Vinson C. CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo. Genome Res 2013; 23:988-97; PMID:23590861; http://dx.doi.org/10.1101/gr.146654.112
   PubMed Web of Science ®Google Scholar
• Alonso MM, Fueyo J, Shay JW, Aldape KD, Jiang H, Lee OH, Johnson DG, Xu J, Kondo Y, Kanzawa T, et al. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst 2005; 97:1589-600; PMID:16264179; http://dx.doi.org/10.1093/jnci/dji340
   PubMed Web of Science ®Google Scholar
• Tríbulo C, Aybar MJ, Sánchez SS, Mayor R. A balance between the anti-apoptotic activity of Slug and the apoptotic activity of msx1 is required for the proper development of the neural crest. Dev Biol 2004; 275:325-42; PMID:15501222; http://dx.doi.org/10.1016/j.ydbio.2004.07.041
   PubMed Web of Science ®Google Scholar
• Monsoro-Burq AH, Wang E, Harland R. Msx1 and Pax3 cooperate to mediate FGF8 and WNT signals during Xenopus neural crest induction. Dev Cell 2005; 8:167-78; PMID:15691759; http://dx.doi.org/10.1016/j.devcel.2004.12.017
   PubMed Web of Science ®Google Scholar
• Hoyt PR, Bartholomew C, Davis AJ, Yutzey K, Gamer LW, Potter SS, Ihle JN, Mucenski ML. The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech Dev 1997; 65:55-70; PMID:9256345; http://dx.doi.org/10.1016/S0925-4773(97)00057-9
   PubMed Web of Science ®Google Scholar
• Kazama H, Kodera T, Shimizu S, Mizoguchi H, Morishita K. Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation. Cell Growth Differ 1999; 10:565-73; PMID:10470856; available at http://cgd.aacrjournals.org/cgi/content/full/10/8/565
   PubMedGoogle Scholar
• Quach DH, Oliveira-Fernandes M, Gruner KA, Tourtellotte WG. A sympathetic neuron autonomous role for Egr3-Mediated gene regulation in dendrite morphogenesis and target tissue innervation. J Neurosci 2013; 33:4570-83; PMID:23467373; http://dx.doi.org/10.1523/JNEUROSCI.5481-12.2013
   PubMed Web of Science ®Google Scholar
• Akahoshi E, Yoshimura S, Ishihara-Sugano M. Over-expression of AhR (aryl hydrocarbon receptor) induces neural differentiation of Neuro2a cells: neurotoxicology study. Environ Health 2006; 5:24; PMID:16956419; http://dx.doi.org/10.1186/1476-069X-5-24
   PubMedGoogle Scholar
• Wu PY, Liao YF, Juan HF, Huang HC, Wang BJ, Lu YL, Yu IS, Shih YY, Jeng YM, Hsu WM, et al. Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma. PLoS One 2014; 9:e88795; PMID:24586395; http://dx.doi.org/10.1371/journal.pone.0088795
   PubMedGoogle Scholar
• Ruffle RA, Mapley AC, Malik MK, Labruzzo SV, Chabla JM, Jose R, Hallas BH, Yu HG, Horowitz JM, Torres G. Distribution of constitutively expressed MEF2A in adult rat and human nervous systems. Synapse 2006; 59:513-20; PMID:16565967; http://dx.doi.org/10.1002/syn.20266
   PubMed Web of Science ®Google Scholar
• Mao Z, Nadal-Ginard B. Functional and physical interactions between mammalian achaete-scute homolog 1 and myocyte enhancer factor 2A. J Biol Chem 1996; 271:14371-5; PMID:8662987; http://dx.doi.org/10.1074/jbc.271.24.14371
   PubMed Web of Science ®Google Scholar
• He Y, Casaccia-Bonnefil P. The Yin and Yang of YY1 in the nervous system. J Neurochem 2008; 106:1493-502; PMID:18485096; http://dx.doi.org/10.1111/j.1471-4159.2008.05486.x
   PubMed Web of Science ®Google Scholar
• Bento-Abreu A, Tabernero A, Medina JM. Peroxisome proliferator-activated receptor-α is required for the neurotrophic effect of oleic acid in neurons. J Neurochem 2007; 103:871-81; PMID:17683485; http://dx.doi.org/10.1111/j.1471-4159.2007.04807.x
   PubMed Web of Science ®Google Scholar
• Dick T, Yang XH, Yeo SL, Chia W. Two closely linked Drosophila POU domain genes are expressed in neuroblasts and sensory elements. Proc Natl Acad Sci USA 1991; 88:7645-9; PMID:1881906; http://dx.doi.org/10.1073/pnas.88.17.7645
   PubMed Web of Science ®Google Scholar
• Ossovskaya VS, Dolganov G, Basbaum AI. Loss of function genetic screens reveal MTGR1 as an intracellular repressor of beta1 integrin-dependent neurite outgrowth. J Neurosci Methods 2009; 177:322-33; PMID:19026687; http://dx.doi.org/10.1016/j.jneumeth.2008.10.031
   PubMed Web of Science ®Google Scholar
• Cameron S, Clark SG, McDermott JB, Aamodt E, Horvitz HR. PAG-3, a Zn-finger transcription factor, determines neuroblast fate in C. elegans. Development 2002; 129:1763-74; PMID:11923211; available at http://dev.biologists.org/content/129/7/1763
   PubMed Web of Science ®Google Scholar
• van Noesel MM. Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest. Lancet Oncol 2012; 13:229-30; PMID:22381931; http://dx.doi.org/10.1016/S1470-2045(12)70012-8
   PubMed Web of Science ®Google Scholar
• Diering GH, Numata Y, Fan S, Church J, Numata M. Endosomal acidification by Na+/H+ exchanger NHE5 regulates TrkA cell-surface targeting and NGF-induced PI3K signaling. Mol Biol Cell 2013; 24:3435-48; PMID:24006492; http://dx.doi.org/10.1091/mbc.E12-06-0445
   PubMed Web of Science ®Google Scholar
• Decock A, Ongenaert M, Hoebeeck J, De Preter K, Van Peer G, Van Criekinge W, Ladenstein R, Schulte JH, Noguera R, Stallings RL, et al. Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers. Genome Biol 2012; 13:R95; PMID:23034519; http://dx.doi.org/10.1186/gb-2012-13-10-r95
   PubMedGoogle Scholar
• Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol 2010; 11:R106; PMID:20979621; http://dx.doi.org/10.1186/gb-2010-11-10-r106
   PubMed Web of Science ®Google Scholar
• Xiao Y, Hsiao TH, Suresh U, Chen HI, Wu X, Wolf SE, Chen Y. A novel significance score for gene selection and ranking. Bioinformatics 2014; 30:801-7; PMID:22321699; http://dx.doi.org/10.1093/bioinformatics/btr671
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57:289-300; available at http://www.jstor.org/stable/2346101
   Web of Science ®Google Scholar
• Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M, Laurila E, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34:267-73; PMID:12808457; http://dx.doi.org/10.1038/ng1180
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43:e47; PMID:25605792; http://dx.doi.org/10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar